U.S. Markets closed

Raymond James: Lumentum Still A 'Strong Buy' Despite Apple's Guidance Cut

Jayson Derrick

The bullish case for optical component supplier Lumentum Holdings Inc (NASDAQ: LITE) remains unchanged despite Apple Inc. (NASDAQ: AAPL) cautioning investors Wednesday afternoon, according to Raymond James.

The Analyst

Raymond James' Simon Leopold maintains a Strong Buy rating on Lumentum with a price target lowered from $87 to $85.

The Thesis

Apple lowered its sales December-ending quarter sales guidance from $91 billion at the midpoint of its prior guidance to around $84 billion and this is "bad news" for component supplier Lumentum, Leopold said in a research note. But the financial impact to Lumentum is likely to be $26 million spread across multiple quarters as Lumentum said in a December conference shipments to Apple continued, which implies Apple's guidance has a lagged effect.

 Lumentum is likely to continue diversifying its business away from Apple and into the Android ecosystem in both optical components and new 3D applications, the analyst said. In fact, a sum-of-the-parts valuation model values Lumentum's stock at $37 to $44 without the 3D prospect, which is near Thursday morning's level. Including the company's 3D prospects would value the stock in a range of $58 to $62.

Bottom line, Lumentum's strength across optical, industrial lasers and a strong outlook for 3D sensing remains unchanged and the stock remains attractive despite the 8 percent decline following Apple's announcement.

Price Action

Shares of Lumentum were trading lower by 9 percent $38.75 Thursday morning.

Related Links:

Lumentum Shares Plunge After Guidance Cut, Bruising Apple Stock In The Process

Analysts Forecast What's Next For Lumentum After The Oclaro Acquisition

Latest Ratings for LITE

Date Firm Action From To
Jan 2019 Raymond James Maintains Strong Buy Strong Buy
Dec 2018 Raymond James Maintains Strong Buy Strong Buy
Nov 2018 UBS Maintains Buy Buy

View More Analyst Ratings for LITE
View the Latest Analyst Ratings

See more from Benzinga

© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.